Inactive Instrument
Precision Therapeutics Inc Stock Nasdaq
Stocks
US74033P1003
Biotechnology & Medical Research
| Market Cap | 71.48M 62.47M 57.64M 53.13M 100M 6.88B 102M 689M 271M 3.37B 268M 263M 11.61B | P/E 2024 |
-0.35x | P/E 2025 | -0.53x |
|---|---|---|---|---|---|
| Enterprise Value | 62.36M 54.49M 50.28M 46.35M 87.36M 6B 89.3M 601M 236M 2.94B 234M 229M 10.12B | EV / Sales 2024 |
4.23x | EV / Sales 2025 | 121x |
| Free-Float |
93.75% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Precision Therapeutics Inc
| 1 day | -7.56% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 09/02/2026 | |
| Director of Finance/CFO | - | 16/04/2026 | |
Kyle Okamoto
PSD | President | - | 01/04/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Daniel Handley
BRD | Director/Board Member | 66 | 19/02/2020 |
Charles L. Nuzum
CHM | Chairman | 78 | 09/02/2026 |
| Director/Board Member | 60 | 09/07/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -7.56% | -8.33% | - | - | 71.48M | ||
| -0.07% | -3.64% | +1.00% | +2.68% | 49.18B | ||
| -0.43% | +0.67% | +381.99% | +590.45% | 39.58B | ||
| +0.17% | +2.84% | +7.08% | +62.06% | 34.69B | ||
| -0.79% | -1.46% | +28.67% | -9.65% | 34.42B | ||
| -1.82% | -1.48% | +0.52% | +32.02% | 27.11B | ||
| -1.25% | -2.64% | - | - | 16.21B | ||
| -0.75% | +0.61% | +72.69% | +116.04% | 15.36B | ||
| +0.85% | +2.04% | +15.17% | +17.96% | 14.05B | ||
| -2.12% | +0.43% | +19.47% | -32.58% | 13.02B | ||
| Average | -1.37% | -0.17% | +65.82% | +97.37% | 27.07B | |
| Weighted average by Cap. | -0.56% | -0.38% | +79.13% | +122.24% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.62M 1.42M 1.31M 1.21M 2.27M 156M 2.33M 15.65M 6.16M 76.59M 6.1M 5.96M 264M | 125K 109K 101K 93.12K 176K 12.07M 179K 1.21M 475K 5.91M 471K 460K 20.34M |
| Net income | -12.66M -11.07M -10.21M -9.41M -17.74M -1.22B -18.14M -122M -48.01M -597M -47.56M -46.52M -2.06B | -233M -204M -188M -173M -327M -22.45B -334M -2.25B -884M -10.99B -875M -856M -37.85B |
| Net Debt | 1.4M 1.22M 1.13M 1.04M 1.96M 134M 2M 13.46M 5.29M 65.86M 5.24M 5.13M 227M | -9.12M -7.97M -7.36M -6.78M -12.78M -879M -13.07M -87.95M -34.59M -430M -34.27M -33.52M -1.48B |
Employees
-

















